ProFarma
Private Company
Funding information not available
Overview
ProFarma is a well-established, privately-held contract service organization (CSO) that provides essential GMP-compliant quality control and batch release services to pharmaceutical companies seeking to commercialize products in the European Union. Its core business model is service-based, generating revenue by offering analytical testing, method development, stability studies, and the legally mandated EU QP certification for imported drug batches. With over 17 years in business and a client base spanning 20+ countries, ProFarma has positioned itself as a key partner for manufacturers navigating complex EU regulatory pathways, particularly for biosimilars and complex generics.
Technology Platform
Integrated GMP-certified analytical laboratory and regulatory compliance infrastructure specializing in EU batch release testing, analytical method development/validation, stability testing, and Qualified Person (QP) certification services.
Opportunities
Risk Factors
Competitive Landscape
ProFarma competes in the fragmented market of contract research organizations (CROs) and analytical testing labs across Europe. Its key differentiator is the integrated offering of GMP testing with the legally mandated EU QP release service, a niche that places it in competition with other authorized batch release sites and the in-house quality control departments of its potential clients.